PubMed for id: 4885467

Year	Number of Results
1991	1
1994	2
1995	2
2020	1
2021	4
2022	1
2024	0

1

MAGE-A3 regulates tumor stemness in gastric cancer through the PI3K/AKT pathway.

Yu QY, Wang ZW, Zhou MY, Li SF, Liao XH. Yu QY, et al. Aging (Albany NY). 2022 Nov 8;14(23):9579-9598. doi: 10.18632/aging.204373. Epub 2022 Nov 8. Aging (Albany NY). 2022. PMID: 36367777 Free PMC article.

2

Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma.

Craig AJ, Garcia-Lezana T, Ruiz de Galarreta M, Villacorta-Martin C, Kozlova EG, Martins-Filho SN, von Felden J, Ahsen ME, Bresnahan E, Hernandez-Meza G, Labgaa I, D'Avola D, Schwartz M, Llovet JM, Sia D, Thung S, Losic B, Lujambio A, Villanueva A. Craig AJ, et al. PLoS Genet. 2021 Jun 24;17(6):e1009589. doi: 10.1371/journal.pgen.1009589. eCollection 2021 Jun. PLoS Genet. 2021. PMID: 34166362 Free PMC article.

3

Immunological and functional aspects of MAGEA3 cancer/testis antigen.

Das B, Senapati S. Das B, et al. Adv Protein Chem Struct Biol. 2021;125:121-147. doi: 10.1016/bs.apcsb.2020.08.001. Epub 2020 Oct 1. Adv Protein Chem Struct Biol. 2021. PMID: 33931137 Review.

4

Nuclear overexpression levels of MAGE-A3 predict poor prognosis in patients with prostate cancer.

Khalvandi A, Abolhasani M, Madjd Z, Shekarabi M, Kourosh-Arami M, Mohsenzadegan M. Khalvandi A, et al. APMIS. 2021 Jun;129(6):291-303. doi: 10.1111/apm.13132. Epub 2021 Apr 13. APMIS. 2021. PMID: 33743542

5

Re-examination of MAGE-A3 as a T-cell Therapeutic Target.

Martin AD, Wang X, Sandberg ML, Negri KR, Wu ML, Toledo Warshaviak D, Gabrelow GB, McElvain ME, Lee B, Daris ME, Xu H, Kamb A. Martin AD, et al. J Immunother. 2021 Apr 1;44(3):95-105. doi: 10.1097/CJI.0000000000000348. J Immunother. 2021. PMID: 33284140 Free PMC article.

6

Cloning and analysis of MAGE-1-related genes.

Ding M, Beck RJ, Keller CJ, Fenton RG. Ding M, et al. Biochem Biophys Res Commun. 1994 Jul 15;202(1):549-55. doi: 10.1006/bbrc.1994.1963. Biochem Biophys Res Commun. 1994. PMID: 8037761

7

Structure, chromosomal localization, and expression of 12 genes of the MAGE family.

De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, van der Bruggen P, Lethé B, Lurquin C, et al. De Plaen E, et al. Immunogenetics. 1994;40(5):360-9. doi: 10.1007/BF01246677. Immunogenetics. 1994. PMID: 7927540

8

Identification and intracellular location of MAGE-3 gene product.

Kocher T, Schultz-Thater E, Gudat F, Schaefer C, Casorati G, Juretic A, Willimann T, Harder F, Heberer M, Spagnoli GC. Kocher T, et al. Cancer Res. 1995 Jun 1;55(11):2236-9. Cancer Res. 1995. PMID: 7757970

9

Expression of MAGE genes in primary and metastatic cutaneous melanoma.

Brasseur F, Rimoldi D, Liénard D, Lethé B, Carrel S, Arienti F, Suter L, Vanwijck R, Bourlond A, Humblet Y, et al. Brasseur F, et al. Int J Cancer. 1995 Nov 3;63(3):375-80. doi: 10.1002/ijc.2910630313. Int J Cancer. 1995. PMID: 7591235

10

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T. van der Bruggen P, et al. Science. 1991 Dec 13;254(5038):1643-7. doi: 10.1126/science.1840703. Science. 1991. PMID: 1840703

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year